Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in Stages III and IV ovarian cancer

David S. Alberts, Stephanie Green, Edward V. Hannigan, Robert O'Toole, Donna Stock-Novack, Patricia Anderson, Earl A. Surwit, Vinay K. Malvlya, William A. Nahhas, Christopher J. Jolies

Research output: Contribution to journalArticlepeer-review

276 Scopus citations

Fingerprint Dive into the research topics of 'Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in Stages III and IV ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences